Browse > Article
http://dx.doi.org/10.15324/kjcls.2022.54.1.15

Changes in C-Reactive Protein and Complete Blood Cell Count According to Procalcitonin Levels  

Kim, Jin-San (Department of Laboratory Medicine, Gangnam CHA Hospital)
Park, Chang-Eun (Department of Biomedical Laboratory Science, Molecular Diagnostics Research Institute, Namseoul University)
Publication Information
Korean Journal of Clinical Laboratory Science / v.54, no.1, 2022 , pp. 15-22 More about this Journal
Abstract
Procalcitonin (PCT) can provide an experimental rationale and a diagnostic lead to distinguish between bacterial and viral infections. This study sought to investigate the clinical characteristics and prognosis of patients with high PCT levels, to improve clinical diagnosis, and to determine whether PCT levels were associated with the subsequent development of sepsis in the general population. This was a retrospective observational study conducted on outpatients (N=127) over a year. The general data and laboratory parameters studied were PCT, C-reactive protein (CRP), and complete blood count (CBC). The positive rates of CRP and white blood cells (WBCs) in the elevated PCT group were higher than those of the normal group (P<0.05); the specificity and sensitivity of the PCT levels were obviously higher than those of the CRP and WBC levels at diagnosis (P<0.05). The mean PCT levels in the low group were significantly higher than those in the high or moderate group (P<0.001). There was a significant positive correlation with CRP, total WBCs, and neutrophils (P<.001). The main finding of this study was the significant association between an elevated PCT level and CRP and WBC levels, signifying a high diagnostic value. This has important implications for the diagnosis of bacterial infections and therapeutic implications for the use of antibiotic treatment in specific patients.
Keywords
Complete blood count; C-reactive protein; Neutrophil; Procalcitonin; Sepsis;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Schuetz P, Aujesky D, Muller C, Muller B. Biomarker-guided personalised emergency medicine for all-hope for another hype? Swiss Med Wkly. 2015;145:w14079. https://doi.org/110.4414/smw.2015.14079
2 Lin KH, Wang FL, Wu MS, Jiang BY, Kao WL, Chao HY, et al. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection in patients with liver cirrhosis: a systematic review and meta-analysis. Diagn Microbiol Infect Dis. 2014;80: 72-78. https://doi.org/10.1016/j.diagmicrobio.2014.03.029   DOI
3 Linscheid P, Seboek D, Schaer DJ, Zulewski H, Keller U, Muller B. Expression and secretion of procalcitonin and calcitonin gene-related peptide by adherent monocytes and by macrophage-activated adipocytes. Crit Care Med. 2004;32:1715-1721. https://doi.org/10.1097/01.ccm.0000134404.63292.71   DOI
4 Park CE. Diagnosis and prognosis of sepsis. Korean J Clin Lab Sci. 2021;53:309-316. https://doi.org/10.15324/kjcls.2021.53.4.309   DOI
5 Lee CC, Chen SY, Tsai CL, Wu SC, Chiang WC, Wang JL, et al. Prognostic value of mortality in emergency department sepsis score, procalcitonin, and C-reactive protein in patients with sepsis at the emergency department. Shock. 2008;29:322-327. https://doi.org/10.1097/shk.0b013e31815077ca   DOI
6 Muller B, White JC, Nylen ES, Snider RH, Becker KL, Habener JF. Ubiquitous expression of the calcitonin-i gene in multiple tissues in response to sepsis. J Clin Endocrinol Metab. 2001;86:396-404. https://doi.org/10.1210/jcem.86.1.7089   DOI
7 Gogos CA, Drosou E, Bassaris HP, Skoutelis A. Pro-versus anti-inflammatory cytokine profile in patients with severe sepsis: a marker for prognosis and future therapeutic options. J Infect Dis. 2000;181:176-180. https://doi.org/10.1086/315214   DOI
8 Lydon EC, Henao R, Burke TW, Aydin M, Nicholson BP, Glickman SW, et al. Validation of a host response test to distinguish bacterial and viral respiratory infection. EBioMedicine. 2019;48:453-461. https://doi.org/10.1016/j.ebiom.2019.09.040   DOI
9 Gilbert DN. Role of procalcitonin in the management of infected patients in the intensive care unit. Infect Dis Clin North Am. 2017;31:435-453. https://doi.org/10.1016/j.idc.2017.05.003   DOI
10 Chen SY, Tsai CL, Lin CH, Lee CC, Chiang WC, Wang JL, et al. Impact of liver cirrhosis on mortality in patients with community-acquired bacteremia. Diagn Microbiol Infect Dis. 2009;64: 124-130. https://doi.org/10.1016/j.diagmicrobio.2009.01.008   DOI
11 Taylor R, Jones A, Kelly S, Simpson M, Mabey J. A review of the value of procalcitonin as a marker of infection. Cureus. 2017; 9:e1148. https://doi.org/10.7759/cureus.1148   DOI
12 Limper M, de Kruif MD, Duits AJ, Brandjes DP, van Gorp EC. The diagnostic role of procalcitonin and other biomarkers in discriminating infectious from non-infectious fever. J Infect. 2010;60: 409-416. https://doi.org/10.1016/j.jinf.2010.03.016   DOI
13 Mitsuma SF, Mansour MK, Dekker JP, Kim J, Rahman MZ, Tweed-Kent A, et al. Promising new assays and technologies for the diagnosis and management of infectious diseases. Clin Infect Dis. 2013;56:996-1002. https://doi.org/10.1093/cid/cis1014   DOI
14 Schuetz P, Raad I, Amin DN. Using procalcitonin-guided algorithms to improve antimicrobial therapy in ICU patients with respiratory infections and sepsis. Curr Opin Crit Care. 2013;19: 453-460. https://doi.org/10.1097/MCC.0b013e328363bd38   DOI
15 Rast AC, Kutz A, Felder S, Faessler L, Steiner D, Laukemann S, et al. Procalcitonin improves the Glasgow Prognostic Score for outcome prediction in emergency patients with cancer: a cohort study. Dis Markers. 2015;2015:795801. https://doi.org/10.1155/2015/795801   DOI
16 Giannakopoulos K, Hoffmann U, Ansari U, Bertsch T, Borggrefe M, Akin I, et al. The use of biomarkers in sepsis: a systematic review. Curr Pharm Biotechnol. 2017;18:499-507. https://doi.org/10.2174/1389201018666170601080111   DOI
17 Hayashida K, Kondo Y, Hara Y, Aihara M, Yamakawa K. Head-to-head comparison of procalcitonin and presepsin for the diagnosis of sepsis in critically ill adult patients: a protocol for a systematic review and meta-analysis. BMJ Open. 2017;7:e014305. https://doi.org/10.1136/bmjopen-2016-014305   DOI
18 Nguyen LJ, Varker A, Slaughter P, Boyle D, Nekahi N. Procalcitonin-guided antibiotic prescribing for acute exacerbations of chronic obstructive pulmonary disease in the Emergency Department. Fed Pract. 2021;38:264-269. https://doi.org/10.12788/fp.0141   DOI